Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPrES 500 – Safety of Invirase 500 mg film-coated tablet boosted with ritonavir in HIV-1 infection
2005-002818-38Phase 3Completed
- Sponsor
- Roche
- Start
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of saquinavir in human immunodeficiency virus infection (HIV) and acquired immunodeficiency syndrome (AIDS), sponsored by Roche. Primary endpoint: Safety and tolerability of saquinavir/ritonavir 1000/100 mg twice daily using the 500 mg film-coated Invirase tablet formulation. Started Dec 2008; status: completed.
02
Drugs
saquinavir
03
Conditions
human immunodeficiency virus infection (HIV)acquired immunodeficiency syndrome (AIDS)
Beyond the preview
Go deeper on 2005-002818-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-002818-38.